PTGX Dec 2024 30.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 10:29AM EDT. Market open.
| Previous Close | 6.44 |
| Open | 6.80 |
| Bid | 2.65 |
| Ask | 4.80 |
| Strike | 30.00 |
| Expire Date | 2024-12-20 |
| Day's Range | 6.44 - 6.80 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 5 |
ACCESSWIREProtagonist Therapeutics to Participate in the Jefferies Global Healthcare Conference 2024
NEWARK, CA / ACCESSWIRE / May 31, 2024 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will participate in a fireside chat and one-on-one meetings ...
- ACCESSWIRE
Protagonist Therapeutics Announces Oral Presentation on Long-Term Follow-up of Rusfertide Phase 2 REVIVE Study Open Label Extension at the European Hematology Association 2024 Congress
NEWARK, CA / ACCESSWIRE / May 14, 2024 / Protagonist Therapeutics, Inc. (NASDAQ:PTGX) ("Protagonist" or the "Company") today announced that additional data from the rusfertide Phase 2 REVIVE open label extension study will be the focus of an oral ...
GuruFocus.comProtagonist Therapeutics Inc (PTGX) Surpasses Q1 Revenue Estimates with Strategic Collaborations
Comprehensive Analysis of Q1 2024 Earnings and Strategic Developments
© 2024 Yahoo. All rights reserved.